Opinion of the President – Health policy program for herpes zoster vaccination – prevention of herpes zoster and herpes zoster neuralgia in the population aged 55 and over for the period 2025-2027

On 21 February 2025, the President of the Agency for Health Technology Assessment and Tariff System issued opinion No. 13/2025 about the draft health policy program “Health policy program for herpes zoster vaccination – prevention of herpes zoster and herpes zoster neuralgia in the population aged 55 and over for the period 2025-2027”

Publication in Public Information Bulletin (BIP) >>